3Dupuis C, Mercier C, Yang C, et al. High - dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy [ J 1. Anticancer Drugs,2008,19 ( 3 ) : 267 - 273. 被引量：1
4Zelcer S, Kellick M, Wexler LH, et al. Methotrexate levels and outcome in osteosarcoma [ J ]. Pediatr Blood Cancer, 2005,44 (7) :638 -642. 被引量：1
5Vezmar S, Becker A, Bode U, et al. Biochemical and clinical aspects of methothrexate neurotoxicity[ J ]. Chemotherapy, 2003,49 (1-2) : 92-104. 被引量：1
6Rask C, AIbert ioni F, Bentzen SM, et al. Clinical and pharmacokinetic risk factors for high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia: a logistic regression analysis [ J ]. Acta Oncol, 1998, 37 (3) : 278-284. 被引量：1
7Evans WE, Relling MV, Boyett JM, et al. Does pharmacokinetic variability influence the efficacy of high dose methotrexate for the treatment of children with acute lymphoblastic leukemia: what can we learn from small studies[J]. Leuk Res, 1997, 21 (5) :435- 437. 被引量：1
8Cohen IJ. Prevention of high-dose-methotrexate neurotoxicity by adequate folinic acid rescue is possible even after central nervous system irradiation [ J ]. Med Hypotheses, 2007, 68 (5) : 1147- 1153. 被引量：1
9Hashiguchi T, Arimura K, Matsumuro K, et al. Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle Nerve, 2000, 23 (7): 1051-1056. 被引量：3
10Ferrari S,Smeland S,Mercuri M,et al. Neoadjuvant chemother-apy with high-dose ifosfamide, high-dose methotrexate, cisplatin,and doxorubicin for patients with localized osteosarcoma of the ex-tremity ? a joint study by the Italian and Scandinavian SarcomaGroups[J]. J Clin Oncol, 2005,23(34) :8845 -8852. 被引量：1
